Sign inJoin waitlistJoin the waitlist

Russell Butterfield

Director · Univ of Utah Sch of Med

Credentials: · · · ·

History

Univ of Utah Sch of Med · Huntsman Cancer Institute & Hospital
Present
Huntsman Cancer Institute & Hospital
Present
Exempla Lutheran Medical Center
Present

Neuromuscular Disorders
University of Utah Hospitals and Clinics GME
2010–2011
Child Neurology
University of Utah Hospitals and Clinics GME
2006–2009
Pediatrics
University of Utah Health
2004–2006
University of Illinois
University of Illinois Urbana-Champaign
2000–2004
Brigham Young University

Research

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Neuromuscular Disorders · 2019 · 497 citations
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program
Neurology · 2021 · 146 citations
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
JAMA · 2022 · 116 citations

NJ
Nicholas Johnson
23 papers
Perry Shieh
16 papers
Katherine Mathews
13 papers
Craig McDonald
12 papers
Jeffrey Statland
11 papers
Nancy Kuntz
11 papers
Rabi Tawil
11 papers
Richard Finkel
11 papers
Emma Ciafaloni
10 papers
Julie Parsons
9 papers
KW
Kathryn Wagner
9 papers
Aravindhan Veerapandiyan
8 papers · 2 as a fellow

Grants

Component A - The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in Utah
NCBDDD · U01
Contact PI · $415K · Utah State Higher Education System--University of Utah
2019–2024
Component C - The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in Utah
NCBDDD · U01
Contact PI · $80K · Utah State Higher Education System--University of Utah
2019–2024
Genetic Control of Phenotypic Variability in Collagen VI Related Muscular Dystrophies
National Institute of Neurological Disorders and Stroke · K08
Contact PI · $1M · Utah State Higher Education System--University of Utah
2016–2021

Clinical trials

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Site PI · Recruiting
University of Kansas Medical Center
2025–2028
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Site PI · Recruiting
Nationwide Children's Hospital
2025–2028
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Site PI · Recruiting
University of Kansas Medical Center
2020–2028
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Site PI · Recruiting
Novartis Pharmaceuticals
2018–2038